Citation: Dm. Araujo et Dc. Hilt, GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR ATTENUATES THE LOCOMOTOR HYPOFUNCTION AND STRIATONIGRAL NEUROCHEMICAL DEFICITS INDUCED BY CHRONIC SYSTEMIC ADMINISTRATION OF THE MITOCHONDRIAL TOXIN 3-NITROPROPIONICACID, Neuroscience, 82(1), 1998, pp. 117-127
Authors:
LAPCHAK PA
ARAUJO DM
HILT DC
JIAO S
COLLIN F
MIYOSHI Y
YI A
ZHANG Z
GASH DM
Citation: Pa. Lapchak et al., TOPOGRAPHICAL DISTRIBUTION OF [I-125] GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR IN UNLESIONED AND MPTP-LESIONED RHESUS-MONKEY BRAIN FOLLOWING A BOLUS INTRAVENTRICULAR-INJECTION, Brain research, 789(1), 1998, pp. 9-22
Citation: Dm. Araujo et Dc. Hilt, GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR ATTENUATES THE EXCITOTOXIN-INDUCED BEHAVIORAL AND NEUROCHEMICAL DEFICITS IN A RODENT MODEL OF HUNTINGTONS-DISEASE, Neuroscience, 81(4), 1997, pp. 1099-1110
Authors:
ARAUJO DM
HILT DC
MILLER PJ
WEN D
JIAO S
LAPCHAK PA
Citation: Dm. Araujo et al., RET RECEPTOR TYROSINE KINASE IMMUNOREACTIVITY IS ALTERED IN GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR-RESPONSIVE NEURONS FOLLOWING LESIONS OF THE NIGROSTRIATAL AND SEPTOHIPPOCAMPAL PATHWAYS, Neuroscience, 80(1), 1997, pp. 9-16
Authors:
LAPCHAK PA
GASH DM
COLLINS F
HILT D
MILLER PJ
ARAUJO DM
Citation: Pa. Lapchak et al., PHARMACOLOGICAL ACTIVITIES OF GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) - PRECLINICAL DEVELOPMENT AND APPLICATION TO THE TREATMENTOF PARKINSONS-DISEASE, Experimental neurology, 145(2), 1997, pp. 309-321
Authors:
LAPCHAK PA
MILLER PJ
JIAO SS
ARAUJO DM
HILT D
COLLINS F
Citation: Pa. Lapchak et al., BIOLOGY OF GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) - IMPLICATIONS FOR THE USE OF GDNF TO TREAT PARKINSONS-DISEASE, Neurodegeneration, 5(3), 1996, pp. 197-205
Citation: Dm. Araujo et Cw. Cotman, DIFFERENTIAL-EFFECTS OF INTERLEUKIN-1-BETA AND INTERLEUKIN-2 ON GLIA AND HIPPOCAMPAL-NEURONS IN CULTURE, International journal of developmental neuroscience, 13(3-4), 1995, pp. 201-212
Citation: Dm. Araujo et Pa. Lapchak, INDUCTION OF IMMUNE-SYSTEM MEDIATORS IN THE HIPPOCAMPAL-FORMATION IN ALZHEIMERS AND PARKINSONS DISEASES - SELECTIVE EFFECTS ON SPECIFIC INTERLEUKINS AND INTERLEUKIN RECEPTORS, Neuroscience, 61(4), 1994, pp. 745-754
Citation: Pa. Lapchak et al., EFFECTS OF CHRONIC NERVE GROWTH-FACTOR TREATMENT ON HIPPOCAMPAL [H-3]CYTISINE NICOTINIC BINDING-SITES AND PRESYNAPTIC NICOTINIC RECEPTOR FUNCTION FOLLOWING FIMBRIAL TRANSECTIONS/, Neuroscience, 60(2), 1994, pp. 293-298
Citation: Pa. Lapchak et Dm. Araujo, EFFECTS OF CHRONIC INTRAVENTRICULAR NERVE GROWTH-FACTOR TREATMENT ON VASOACTIVE-INTESTINAL-PEPTIDE AND NEUROPEPTIDE-Y LEVELS IN THE HIPPOCAMPAL-FORMATION AND CEREBRAL-CORTEX FOLLOWING FIMBRIAL TRANSECTIONS, Brain research, 654(1), 1994, pp. 1-7
Citation: Pa. Lapchak et al., DISTRIBUTION OF [I-125] NERVE GROWTH-FACTOR IN THE RAT-BRAIN FOLLOWING A SINGLE INTRAVENTRICULAR-INJECTION - CORRELATION WITH THE TOPOGRAPHICAL DISTRIBUTION OF TRKA MESSENGER RNA-EXPRESSING CELLS, Neuroscience, 54(2), 1993, pp. 445-460
Citation: Dm. Araujo et al., EFFECTS OF CHRONIC BASIC FIBROBLAST GROWTH-FACTOR ADMINISTRATION TO RATS WITH PARTIAL FIMBRIAL TRANSECTIONS ON PRESYNAPTIC CHOLINERGIC PARAMETERS AND MUSCARINIC RECEPTORS IN THE HIPPOCAMPUS - COMPARISON WITH NERVE GROWTH-FACTOR, Journal of neurochemistry, 61(3), 1993, pp. 899-910
Citation: Pa. Lapchak et al., DIFFERENTIAL ALTERATIONS OF CORTICAL CHOLINERGIC AND NEUROTENSIN MARKERS FOLLOWING IBOTENIC ACID LESIONS OF THE NUCLEUS BASALIS MAGNOCELLULARIS, Brain research, 613(2), 1993, pp. 239-246